We are a leading designer, manufacturer and marketer of a range of innovative healthcare devices which incorporate unique features to improve patient care.

Fisher & Paykel entered the respiratory care market in 1971 with the development of a unique respiratory humidifier system for use in critical care. We now offer a broad range of products and systems for use in respiratory and acute care and the treatment of obstructive sleep apnea (OSA).

A RECORD OF GROWTH
Our people, clinical research, leading technologies and expanding markets have driven our growth with a focus on increasing shareholder value.

INTERNATIONAL REACH
Our headquarters and research facilities are based in New Zealand, with manufacturing facilities located in New Zealand and Mexico.

In total, our products are sold in more than 120 countries either directly by our offices or through distributors and OEMs. We support our customers with sales and marketing operations located in 30 countries.
ND DEVELOPMENT
We believe that product development and clinical research are critical to our success. A significant proportion of our New Zealand based workforce is engaged in clinical research and product and process development.

RESPIRATORY AND ACUTE CARE
We offer a broad range of heated humidification products and systems for use during the treatment of respiratory conditions by ventilation or oxygen therapy. Our products include respiratory humidifiers, single-use and reusable chambers and breathing circuits, infant resuscitators, infant warrmers and accessories.

Incorporating patented and other proprietary technologies, our respiratory devices are designed to overcome many of the challenges of effectively creating, controlling and delivering gases to a patient's airway at close to physiologically normal levels of temperature and humidity.

We also offer humidification systems for use in surgical procedures to condition dry carbon dioxide gas to normal physiological levels of temperature and humidity.

Our products incorporate technologies designed to reduce the level of required caregiver intervention in the humidification process, and we believe may decrease the risk of infection, improve patient recovery rates and reduce patient care costs.

OBSTRUCTIVE SLEEP APNEA
We offer continuous positive airway pressure (CPAP) therapy products and systems for the treatment of obstructive sleep apnea, a disorder which disrupts a person's breathing during sleep.

Our products include flow generators, chambers, masks and other accessories. Our humidifier products utilize our core expertise in heated humidification and are designed to alleviate the side effects often associated with CPAP therapy.

We believe that our products improve patient comfort and acceptance of CPAP therapy, contributing to an increase in its overall effectiveness.

The sleep disordered breathing market is growing rapidly. It is estimated that at least 12 million people in the USA, and many millions more worldwide, suffer from obstructive sleep apnea.